Oshi, M.; Newman, S.; Tokumaru, Y.; Yan, L.; Matsuyama, R.; Endo, I.; Katz, M.H.G.; Takabe, K.
High G2M Pathway Score Pancreatic Cancer is Associated with Worse Survival, Particularly after Margin-Positive (R1 or R2) Resection. Cancers 2020, 12, 2871.
https://doi.org/10.3390/cancers12102871
AMA Style
Oshi M, Newman S, Tokumaru Y, Yan L, Matsuyama R, Endo I, Katz MHG, Takabe K.
High G2M Pathway Score Pancreatic Cancer is Associated with Worse Survival, Particularly after Margin-Positive (R1 or R2) Resection. Cancers. 2020; 12(10):2871.
https://doi.org/10.3390/cancers12102871
Chicago/Turabian Style
Oshi, Masanori, Stephanie Newman, Yoshihisa Tokumaru, Li Yan, Ryusei Matsuyama, Itaru Endo, Matthew H. G. Katz, and Kazuaki Takabe.
2020. "High G2M Pathway Score Pancreatic Cancer is Associated with Worse Survival, Particularly after Margin-Positive (R1 or R2) Resection" Cancers 12, no. 10: 2871.
https://doi.org/10.3390/cancers12102871
APA Style
Oshi, M., Newman, S., Tokumaru, Y., Yan, L., Matsuyama, R., Endo, I., Katz, M. H. G., & Takabe, K.
(2020). High G2M Pathway Score Pancreatic Cancer is Associated with Worse Survival, Particularly after Margin-Positive (R1 or R2) Resection. Cancers, 12(10), 2871.
https://doi.org/10.3390/cancers12102871